Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients. Issue 1 (January 2023)

• Record Type: Journal Article
• Authors: Brescia, Fabrizio; Pittiruti, Mauro; Scoppettuolo, Giancarlo; Zanier, Chiara; Nadalini, Elisa; Bottos, Paola; Moreal, Chiara; Da Ros, Valentina; Fabiani, Fabio
• Is Part Of: Journal of vascular access. Volume 24:Issue 1(2023)
• Page Start: 87
• Page End: 91
• Publication Date: 2023-01
• Subjects: Oncology access -- techniques and procedures -- catheter-related bloodstream infection -- catheter-colonization -- taurolidine lock; Arterial catheterization -- Periodicals; Intravenous catheterization -- Periodicals; 612.13
• DOI: 10.1177/11297298211026453
• Languages: English
• ISSNs: 1129-7298

Abstract

Background: Taurolidine lock is known to be effective in preventing catheter-related infections in a variety of venous access devices, including long term venous access devices for chemotherapy. Though, literature about the use of taurolidine for treating catheter colonization or catheter-related blood stream infection is scarce. Method: We have retrospectively reviewed the safety and efficacy of 2% taurolidine lock for treatment of catheter-colonization and of catheter-related bloodstream infection in cancer patients with totally implanted venous access devices. Diagnosis of colonization or catheter-related infection was based on paired peripheral and central blood cultures, according to the method of Delayed Time to Positivity. Results: We recorded 24 cases of catheter-related infection and two cases of colonization. Taurolidine lock—associated with systemic antibiotic therapy—was successful in treating all cases of catheter-related infection, with disappearance of clinical symptoms, normalization of laboratory values, and eventually negative blood cultures. Taurolidine lock was also safe and effective in treating device colonization. No adverse effect was reported. Conclusion: In our retrospective analysis, 2% taurolidine lock was completely safe and highly effective in the treatment of both catheter-colonization and catheter-related bloodstream infection in cancer patients with totally implanted venous access devices.